APA (7th ed.) Citation

Stiekema, L. C. A., Stroes, E. S. G., Verweij, S. L., Kassahun, H., Chen, L., Wasserman, S. M., . . . Fayad, Z. A. (2019). Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment. European heart journal, 40(33), 2775-2781. https://doi.org/10.1093/eurheartj/ehy862

Chicago Style (17th ed.) Citation

Stiekema, Lotte C A., Erik S G. Stroes, Simone L. Verweij, Helina Kassahun, Lisa Chen, Scott M. Wasserman, Marc S. Sabatine, Venkatesh Mani, and Zahi A. Fayad. "Persistent Arterial Wall Inflammation in Patients with Elevated Lipoprotein(a) Despite Strong Low-density Lipoprotein Cholesterol Reduction by Proprotein Convertase Subtilisin/kexin Type 9 Antibody Treatment." European Heart Journal 40, no. 33 (2019): 2775-2781. https://doi.org/10.1093/eurheartj/ehy862.

MLA (9th ed.) Citation

Stiekema, Lotte C A., et al. "Persistent Arterial Wall Inflammation in Patients with Elevated Lipoprotein(a) Despite Strong Low-density Lipoprotein Cholesterol Reduction by Proprotein Convertase Subtilisin/kexin Type 9 Antibody Treatment." European Heart Journal, vol. 40, no. 33, 2019, pp. 2775-2781, https://doi.org/10.1093/eurheartj/ehy862.